A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 39 (6) , 657-664
- https://doi.org/10.1016/0090-6980(90)90025-q
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: A placebo-controlled cross-over studyJournal of Molecular Medicine, 1984
- EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASEThe Lancet, 1983
- INTRAVENOUS PROSTACYCLIN FOR ISCHAEMIC ULCERS IN PERIPHERAL ARTERY DISEASEThe Lancet, 1980
- Prostacyclin therapy in peripheral arterial diseaseThrombosis Research, 1980
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976